Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'
China’s science surge is reshaping global drug development as Washington moves to counter Beijing’s growing influence in medicine.
Drug companies around the world are working more with Chinese scientists because China is getting really good at medical research. When you see these companies' news, think about whether they're building partnerships in China or pulling away—it shows how they're planning to grow.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.